Mirum Pharmaceuticals, Inc. MIRM Accounts payable, accrued expenses and other liabilities

Accounts payable, accrued expenses and other liabilities at other companies

Virtu FinancialVIRT

-$60.12M-90.0%

Virtu FinancialVIRT

$568.46M+15.3%

Virtu FinancialVIRT

-$60.12M-90.0%

Innovative Industrial Properties, Inc.IIPR

$3.98M+152%

BFS

Saul CentersBFS

$42.35M-6.2%

loanDepotLDI

$346.64M-3.3%

FAQ

What is Mirum Pharmaceuticals, Inc.'s accounts payable, accrued expenses and other liabilities?

Mirum Pharmaceuticals, Inc. (MIRM) reported accounts payable, accrued expenses and other liabilities of $57.24M in Q1 2026.

How has Mirum Pharmaceuticals, Inc.'s accounts payable, accrued expenses and other liabilities changed year-over-year?

Mirum Pharmaceuticals, Inc.'s accounts payable, accrued expenses and other liabilities increased by 387.7% year-over-year, from $11.74M to $57.24M.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accounts payable, accrued expenses and other liabilities?

Over 3 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s accounts payable, accrued expenses and other liabilities has grown at a 87.1% compound annual growth rate (CAGR), from $7.64M to $50.1M.

What does accounts payable, accrued expenses and other liabilities mean?

This metric tracks the net change in short-term obligations owed to suppliers, service providers, and other creditors. An increase indicates that the company is effectively utilizing trade credit to manage working capital, while a decrease suggests cash outflows to settle these liabilities. It serves as a primary indicator of short-term liquidity management.